PMC:7205724 / 108-288 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":144,"end":151},"obj":"Species"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":24,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":45,"end":60},"obj":"Chemical"},{"id":"T3","span":{"begin":113,"end":128},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":24,"end":39},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T1","span":{"begin":45,"end":60},"obj":"Chemical"},{"id":"T2","span":{"begin":113,"end":128},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T3","span":{"begin":7,"end":60},"obj":"Sentence"},{"id":"T4","span":{"begin":62,"end":72},"obj":"Sentence"},{"id":"T5","span":{"begin":73,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"3","span":{"begin":144,"end":151},"obj":"Species"}],"attributes":[{"id":"A3","pred":"pubann:denotes","subj":"3","obj":"Tax:9606"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T16","span":{"begin":5,"end":6},"obj":"-COLON-"},{"id":"T17","span":{"begin":7,"end":22},"obj":"NNS"},{"id":"T18","span":{"begin":22,"end":23},"obj":"-COMMA-"},{"id":"T19","span":{"begin":24,"end":39},"obj":"NNS"},{"id":"T20","span":{"begin":39,"end":40},"obj":"-COMMA-"},{"id":"T21","span":{"begin":41,"end":44},"obj":"CC"},{"id":"T22","span":{"begin":45,"end":60},"obj":"NNS"},{"id":"T23","span":{"begin":62,"end":72},"obj":"NNS"},{"id":"T24","span":{"begin":73,"end":74},"obj":"IN"},{"id":"T25","span":{"begin":76,"end":80},"obj":"NNP"},{"id":"T26","span":{"begin":80,"end":81},"obj":"-COMMA-"},{"id":"T27","span":{"begin":82,"end":90},"obj":"VBN"},{"id":"T28","span":{"begin":91,"end":95},"obj":"IN"},{"id":"T29","span":{"begin":96,"end":109},"obj":"NN"},{"id":"T30","span":{"begin":110,"end":112},"obj":"IN"},{"id":"T31","span":{"begin":113,"end":128},"obj":"NNS"},{"id":"T32","span":{"begin":128,"end":129},"obj":"-COMMA-"},{"id":"T33","span":{"begin":130,"end":135},"obj":"MD"},{"id":"T34","span":{"begin":136,"end":143},"obj":"VB"},{"id":"T35","span":{"begin":144,"end":151},"obj":"NN"},{"id":"T36","span":{"begin":152,"end":160},"obj":"NNS"},{"id":"T37","span":{"begin":162,"end":163},"obj":"PDT"},{"id":"T38","span":{"begin":165,"end":168},"obj":"DT"},{"id":"T39","span":{"begin":169,"end":172},"obj":"NN"},{"id":"T40","span":{"begin":173,"end":175},"obj":"IN"}],"relations":[{"id":"R15","pred":"arg1Of","subj":"T17","obj":"T18"},{"id":"R16","pred":"arg2Of","subj":"T19","obj":"T18"},{"id":"R17","pred":"arg1Of","subj":"T21","obj":"T20"},{"id":"R18","pred":"arg1Of","subj":"T18","obj":"T21"},{"id":"R19","pred":"arg2Of","subj":"T22","obj":"T21"},{"id":"R20","pred":"arg1Of","subj":"T25","obj":"T24"},{"id":"R21","pred":"arg1Of","subj":"T25","obj":"T26"},{"id":"R22","pred":"arg2Of","subj":"T25","obj":"T27"},{"id":"R23","pred":"arg1Of","subj":"T27","obj":"T28"},{"id":"R24","pred":"arg2Of","subj":"T29","obj":"T28"},{"id":"R25","pred":"arg1Of","subj":"T29","obj":"T30"},{"id":"R26","pred":"arg2Of","subj":"T31","obj":"T30"},{"id":"R27","pred":"arg1Of","subj":"T34","obj":"T32"},{"id":"R28","pred":"arg1Of","subj":"T25","obj":"T33"},{"id":"R29","pred":"arg2Of","subj":"T34","obj":"T33"},{"id":"R30","pred":"arg1Of","subj":"T25","obj":"T34"},{"id":"R31","pred":"arg2Of","subj":"T36","obj":"T34"},{"id":"R32","pred":"arg1Of","subj":"T36","obj":"T35"},{"id":"R33","pred":"arg1Of","subj":"T39","obj":"T37"},{"id":"R34","pred":"arg1Of","subj":"T39","obj":"T38"},{"id":"R35","pred":"arg1Of","subj":"T39","obj":"T40"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":24,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":7,"end":60},"obj":"Sentence"},{"id":"T4","span":{"begin":62,"end":72},"obj":"Sentence"},{"id":"T5","span":{"begin":73,"end":161},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"gents: Anti-antibodies, immunoglobulins, and corticosteroids\n\nHighlights\n• IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.\n• The use of cort"}